Get the Stockscreener App
3.935
344.63%
3.05
EAGLE PHARMS INC Stock (EGRX) Forecast
The EAGLE PHARMS INC (EGRX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.8059, representing a -28.69% decrease from the current price of $3.935. The highest analyst price target is $4.2453, and the lowest is $1.3665.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EGRX Price Target
Average 2.8059
(-28.69% Downside)
Is EAGLE PHARMS INC (EGRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 83.81 | Sell |
| STOCH(9,6) | 79.28 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.3534 | Buy |
| ADX(14) | 29.17 | Buy |
| William %R | 0.00 | Sell |
| CCI(14) | 427.34 | Buy |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.229
Buy
|
1.4397
Buy
|
| MA20 |
0.9896
Buy
|
1.0962
Buy
|
| MA50 |
0.6541
Buy
|
0.7809
Buy
|
| MA100 |
0.4964
Buy
|
0.7225
Buy
|
| MA200 |
0.3952
Buy
|
0.00
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, EGRX could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 3 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on EGRX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 83.81 indicates that EGRX is overbought. This suggests that EGRX price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 79.28 indicates that EGRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that EGRX is oversold. This suggests that EGRX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.17 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 427.34 indicates that EGRX is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term EGRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about EAGLE PHARMS INC financial reports and earnings history, EAGLE PHARMS INC (EGRX) stock could reach $7.9811 by 2030, $20.58 by 2040 and $31.64 by 2050. See the projected annual prices until 2050 of the EAGLE PHARMS INC stock below:
- EAGLE PHARMS INC (EGRX) is expected to reach an average price of $14.58 in 2035, with a high prediction of $14.58 and a low estimate of $13.42. This indicates an $270.64% rise from the last recorded price of $3.935.
- EAGLE PHARMS INC (EGRX) stock is projected to chart a bullish course in 2040, with an average price target of $20.57, representing an $422.85% surge from its current level. The forecast ranges from a conservative $19.88 to a sky-high $20.58.
- Our analysts predict EAGLE PHARMS INC (EGRX) to jump 557.51% by 2045, soaring from $25.15 to an average price of $25.87, potentially reaching $26.22. While $25.15 is the low estimate, the potential upside is significant.
- EAGLE PHARMS INC (EGRX) stock is expected to climb by 2050, reaching an average of $30.61, a $677.98% jump from its current level. However, a wide range of estimates exists, with high and low targets of $31.64 and $28.99, respectively, highlighting the market's uncertainty.
EAGLE PHARMS INC Stock (EGRX) Year by Year Forecast
EAGLE PHARMS INC Stock (EGRX) Price Forecast for 2026
The predicted value for EAGLE PHARMS INC (EGRX) in 2026 is set at an average of $2.1232. Estimates vary from a peak of $4.2453 to a trough of $0.0011, indicating an -46.04% surge from the present price of $3.935.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $2.2761 | $1.3665 | $4.2453 | -42.16% |
| December, 2026 | $1.8274 | $1.4176 | $3.1172 | -53.56% |
EAGLE PHARMS INC Stock (EGRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for EAGLE PHARMS INC (EGRX) is $3.5814, with a high forecast of $5.7246 and a low forecast of $1.4381. This indicates an -8.99% decrease from the last price of $3.935.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.6985 | $1.4381 | $2.0377 | -56.84% |
| February, 2027 | $1.9096 | $1.51 | $2.2596 | -51.47% |
| March, 2027 | $1.661 | $1.5203 | $2.1199 | -57.79% |
| April, 2027 | $1.587 | $1.4723 | $2.127 | -59.67% |
| May, 2027 | $1.8931 | $1.5973 | $1.8931 | -51.89% |
| June, 2027 | $1.9795 | $1.5959 | $2.0695 | -49.70% |
| July, 2027 | $2.2506 | $1.6267 | $2.3253 | -42.81% |
| August, 2027 | $1.7275 | $1.7127 | $2.3158 | -56.10% |
| September, 2027 | $1.8893 | $1.7374 | $2.6327 | -51.99% |
| October, 2027 | $2.7391 | $1.9183 | $3.0233 | -30.39% |
| November, 2027 | $5.4905 | $1.8894 | $5.7246 | +39.53% |
| December, 2027 | $4.0933 | $2.6221 | $4.7111 | +4.02% |
EAGLE PHARMS INC Stock (EGRX) Price Forecast for 2028
In 2028, EAGLE PHARMS INC (EGRX) is projected to reach an average price of $5.1245, with a high projection of $7.5143 and a low estimate of $2.7347. This indicates an +30.23% rise from the last price of $3.935.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.3754 | $2.7347 | $4.4343 | -14.22% |
| February, 2028 | $3.4576 | $2.8169 | $3.4576 | -12.13% |
| March, 2028 | $3.1103 | $2.9196 | $3.6692 | -20.96% |
| April, 2028 | $3.0925 | $2.9436 | $3.4925 | -21.41% |
| May, 2028 | $3.2952 | $3.0052 | $3.6291 | -16.26% |
| June, 2028 | $3.6023 | $3.1668 | $3.6023 | -8.45% |
| July, 2028 | $3.7845 | $3.1904 | $3.7845 | -3.82% |
| August, 2028 | $3.9072 | $3.2417 | $3.9617 | -0.71% |
| September, 2028 | $3.9244 | $3.4037 | $3.9688 | -0.27% |
| October, 2028 | $4.7615 | $3.5952 | $4.7615 | +21.00% |
| November, 2028 | $7.5143 | $3.6687 | $7.5143 | +90.96% |
| December, 2028 | $5.2974 | $3.8776 | $6.7358 | +34.62% |
EAGLE PHARMS INC Stock (EGRX) Price Forecast for 2029
The 2029 price forecast for EAGLE PHARMS INC Stock (EGRX) is $6.6779 on average, with a high prediction of $9.3039 and a low estimate of $4.0519. This represents an +69.70% increase from the previous price of $3.935.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.7315 | $4.0519 | $5.7515 | +20.24% |
| February, 2029 | $4.3748 | $4.1135 | $5.5073 | +11.18% |
| March, 2029 | $4.578 | $4.4056 | $4.8364 | +16.34% |
| April, 2029 | $4.5713 | $4.3292 | $5.0788 | +16.17% |
| May, 2029 | $4.8164 | $4.4148 | $4.9637 | +22.40% |
| June, 2029 | $4.9397 | $4.5072 | $5.1311 | +25.53% |
| July, 2029 | $5.1018 | $4.7144 | $5.166 | +29.65% |
| August, 2029 | $5.4759 | $4.7848 | $5.5759 | +39.16% |
| September, 2029 | $5.3691 | $4.9084 | $5.6133 | +36.45% |
| October, 2029 | $5.9032 | $5.0803 | $6.0682 | +50.02% |
| November, 2029 | $6.2264 | $5.3453 | $6.4998 | +58.23% |
| December, 2029 | $7.64 | $5.4481 | $9.3039 | +94.16% |
EAGLE PHARMS INC Stock (EGRX) Price Forecast for 2030
EAGLE PHARMS INC Stock (EGRX) is expected to reach an average price of $6.6856 in 2030, with a high forecast of $8.2381 and a low forecast of $5.1332. This signifies an +69.90% surge from the last price of $3.935.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.8454 | $5.1332 | $7.9811 | +48.55% |
| February, 2030 | $5.8098 | $5.3691 | $7.0687 | +47.64% |
| March, 2030 | $5.8041 | $5.4512 | $6.103 | +47.50% |
| April, 2030 | $6.1384 | $5.7388 | $6.4884 | +56.00% |
| May, 2030 | $6.0438 | $5.7799 | $6.3795 | +53.59% |
| June, 2030 | $6.0932 | $5.886 | $6.6332 | +54.85% |
| July, 2030 | $6.5936 | $6.1343 | $6.5986 | +67.56% |
| August, 2030 | $6.7629 | $6.3547 | $6.8529 | +71.87% |
| September, 2030 | $7.1573 | $6.4718 | $7.2012 | +81.89% |
| October, 2030 | $7.3427 | $6.6683 | $7.3427 | +86.60% |
| November, 2030 | $7.0733 | $6.939 | $7.7859 | +79.75% |
| December, 2030 | $8.0463 | $7.1331 | $8.2381 | +104.48% |
Cap:
|
Volume (24h):